News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hospira, Inc. (HSP) Reports Second-Quarter 2013 Results


7/31/2013 6:50:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2013. Net sales for the quarter were $1.0 billion and adjusted* diluted earnings per share were $0.55. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles (GAAP) basis, diluted earnings per share were $0.20. Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today reported results for the second quarter ended June 30, 2013. Net sales for the quarter were $1.0 billion and adjusted* diluted earnings per share were $0.55. (Adjusted* measures exclude certain specified items as described later in this press release and the attached schedules.) On a U.S. Generally Accepted Accounting Principles (GAAP) basis, diluted earnings per share were $0.20.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES